Preoperative total parathyroid volume is an independent marker to predict recurrence for secondary hyperparathyroidism.

Annals of medicine Pub Date : 2024-12-01 Epub Date: 2024-11-12 DOI:10.1080/07853890.2024.2428435
Zhongkui Wang, Fuquan Zhang, Chengpei Zhu, Chunyue Wu, Xiangchao Meng, Xudong Wang
{"title":"Preoperative total parathyroid volume is an independent marker to predict recurrence for secondary hyperparathyroidism.","authors":"Zhongkui Wang, Fuquan Zhang, Chengpei Zhu, Chunyue Wu, Xiangchao Meng, Xudong Wang","doi":"10.1080/07853890.2024.2428435","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to explore the value of preoperative total parathyroid volume (TPV) as a marker for predict recurrence of renal secondary hyperparathyroidism (SHPT).</p><p><strong>Methods: </strong>We identified 28 patients with recurrence and 128 without recurrence who underwent total parathyroidectomy with autotransplantation (tPTX + AT) at our institution between 2015 and 2022. The TPV and postoperative recurrence information of the patients were recorded. Within the intergroup comparison, data obtained from the recurrence and non-recurrence groups were evaluated using the t-test. Univariate and multivariate analyses were performed according to the regression model to determine factors that were significant in predicting postoperative recurrence. The cutoff value of TPV was determined using a receiver operating characteristic (ROC) curve.</p><p><strong>Results: </strong>The mean TPV of recurrence and no-recurrence groups were 2.99 ± 1.52 cm<sup>3</sup> and 1.73 ± 1.19 cm<sup>3</sup>, respectively (<i>p</i> = 0.007). In univariate analysis, female sex, total parathyroid volume > 1.99 cm<sup>3</sup>, serum PTH > 928.37 pg/mL and <i>p</i> > 1.59 mmol/L were independent factors for SHPT recurrence. In multivariable analysis, TPV > 1.99 cm<sup>3</sup>, serum parathyroid hormone (PTH) > 928.37 pg/mL and <i>p</i> > 1.59 mmol/L were independent factors for SHPT recurrence. The ability of TPV to distinguish between recurrence and non-recurrence was evaluated using the ROC curve. The cutoff value of TPV was estimated as 2.65 cm<sup>3</sup>. With this value, sensitivity was found as 60.70%, specificity was 89.80%, and AUC was 0.80 (<i>p</i> < 0.001, confidence interval =0.719-0.882).</p><p><strong>Conclusion: </strong>According to the data in this study, it can be said that TPV can be used to distinguish recurrence from no-recurrence. Most importantly, TPV can be used to identify SHPT recurrence.</p>","PeriodicalId":93874,"journal":{"name":"Annals of medicine","volume":"56 1","pages":"2428435"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559028/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/07853890.2024.2428435","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/12 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study aimed to explore the value of preoperative total parathyroid volume (TPV) as a marker for predict recurrence of renal secondary hyperparathyroidism (SHPT).

Methods: We identified 28 patients with recurrence and 128 without recurrence who underwent total parathyroidectomy with autotransplantation (tPTX + AT) at our institution between 2015 and 2022. The TPV and postoperative recurrence information of the patients were recorded. Within the intergroup comparison, data obtained from the recurrence and non-recurrence groups were evaluated using the t-test. Univariate and multivariate analyses were performed according to the regression model to determine factors that were significant in predicting postoperative recurrence. The cutoff value of TPV was determined using a receiver operating characteristic (ROC) curve.

Results: The mean TPV of recurrence and no-recurrence groups were 2.99 ± 1.52 cm3 and 1.73 ± 1.19 cm3, respectively (p = 0.007). In univariate analysis, female sex, total parathyroid volume > 1.99 cm3, serum PTH > 928.37 pg/mL and p > 1.59 mmol/L were independent factors for SHPT recurrence. In multivariable analysis, TPV > 1.99 cm3, serum parathyroid hormone (PTH) > 928.37 pg/mL and p > 1.59 mmol/L were independent factors for SHPT recurrence. The ability of TPV to distinguish between recurrence and non-recurrence was evaluated using the ROC curve. The cutoff value of TPV was estimated as 2.65 cm3. With this value, sensitivity was found as 60.70%, specificity was 89.80%, and AUC was 0.80 (p < 0.001, confidence interval =0.719-0.882).

Conclusion: According to the data in this study, it can be said that TPV can be used to distinguish recurrence from no-recurrence. Most importantly, TPV can be used to identify SHPT recurrence.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
术前甲状旁腺总体积是预测继发性甲状旁腺功能亢进症复发的独立指标。
目的:本研究旨在探讨术前甲状旁腺总体积(TPV)作为预测肾性继发性甲状旁腺功能亢进症(SHPT)复发标志物的价值:我们确定了2015年至2022年间在本院接受甲状旁腺全切除术+自体移植术(tPTX + AT)的28例复发患者和128例未复发患者。我们记录了患者的TPV和术后复发信息。在组间比较中,采用t检验对复发组和未复发组获得的数据进行评估。根据回归模型进行单变量和多变量分析,以确定对预测术后复发有重要意义的因素。使用接收器操作特征曲线(ROC)确定TPV的临界值:复发组和未复发组的平均 TPV 分别为 2.99 ± 1.52 cm3 和 1.73 ± 1.19 cm3(P = 0.007)。在单变量分析中,女性性别、甲状旁腺总体积> 1.99 cm3、血清PTH> 928.37 pg/mL和p> 1.59 mmol/L是SHPT复发的独立因素。在多变量分析中,TPV > 1.99 cm3、血清甲状旁腺激素(PTH)> 928.37 pg/mL和p > 1.59 mmol/L是SHPT复发的独立因素。采用ROC曲线评估了TPV区分复发和未复发的能力。TPV 的临界值估计为 2.65 立方厘米。在此值下,灵敏度为 60.70%,特异度为 89.80%,AUC 为 0.80(p 结论):根据本研究的数据,可以说 TPV 可用来区分复发和未复发。最重要的是,TPV 可用来识别 SHPT 复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Evaluating the efficacy and safety of polyglycolic acid-loading mitomycin nanoparticles in inhibiting the scar proliferation after glaucoma filtering surgery. Development and application of an uncapped mRNA platform. Overexpression of ST8Sia1 inhibits tumor progression by TGF-β1 signaling in rectal adenocarcinoma and promotes the tumoricidal effects of CD8+ T cells by granzyme B and perforin. Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study. Prognostic indicators and outcome in patients with acute liver failure, sepsis and with and without shock: a retrospective cohort study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1